HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A double-blind comparative study of remoxipride and haloperidol in schizophrenic and schizophreniform disorders.

Abstract
The antipsychotic effect of remoxipride was compared to that of haloperidol in a randomized double-blind study with parallel group design comprising 98 patients with schizophrenia or schizophreniform disorder according to DSM-III. After a 3-7 day placebo washout period, patients received either 150-600 mg of remoxipride or 5-20 mg of haloperidol daily for 6 weeks. No significant differences in efficacy were found between the two treatments. Treatment-emergent checklist symptoms such as hypokinesia, rigidity, and tremor occurred more frequently and were more severe during haloperidol than during remoxipride treatment despite a significantly higher concurrent use of anticholinergic drugs in the haloperidol group. Haloperidol-treated patients reported greater increases in sleep and salivation than remoxipride-treated patients. Shoulder shaking and tremor were reported as occurring more frequently in the haloperidol group according to the Simpson and Angus rating scale for extrapyramidal symptoms. In summary, the two drugs seemed to be equally efficacious, though the tolerability profile favoured remoxipride.
AuthorsJ Mendlewicz, E de Bleeker, P Cosyns, G Deleu, F Lotstra, A Masson, C Mertens, M Parent, J Peuskens, E Suy
JournalActa psychiatrica Scandinavica. Supplementum (Acta Psychiatr Scand Suppl) Vol. 358 Pg. 138-41 ( 1990) ISSN: 0065-1591 [Print] Denmark
PMID1978474 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • Antipsychotic Agents
  • Benzamides
  • Remoxipride
  • Haloperidol
Topics
  • Adult
  • Aged
  • Antipsychotic Agents (adverse effects, therapeutic use)
  • Basal Ganglia Diseases (etiology)
  • Benzamides (adverse effects, therapeutic use)
  • Double-Blind Method
  • Female
  • Haloperidol (adverse effects, therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • Neurologic Examination
  • Psychiatric Status Rating Scales
  • Psychotic Disorders (drug therapy)
  • Remoxipride
  • Schizophrenia (drug therapy)
  • Schizophrenic Psychology

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: